VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CADL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CADLCandel Therapeutics, Inc.
$9.85$541M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCADLQuarterly Financials

Candel Therapeutics, Inc. (CADL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Candel Therapeutics, Inc. (CADL) quarterly income statement — complete revenue, gross profit & net income history

CADL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue000000000000031K31K31K31K31K31K31K
Revenue Growth %----------100%-100%-100%-100%0%0%0%0%0%--
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit000000000000031K31K31K31K31K31K31K
Gross Margin %-------------100%100%100%100%100%100%100%
Gross Profit Growth %----------100%-100%-100%-100%0%0%0%0%0%--
Operating Expenses16.28M15.75M13.21M11.18M8.13M8.14M8.76M8.57M7.9M10.32M8.86M9.58M9.63M8.08M8.91M8.78M9.02M7.62M7.93M4.73M
OpEx % of Revenue-------------26077.42%28748.39%28335.48%29087.1%24587.1%25577.42%15248.39%
Selling, General & Admin6.44M4.72M4.75M4.19M4.11M3.32M3.34M3.59M3.8M3.06M3.02M3.65M4.16M3.16M3.54M3.76M3.6M3.92M2.79M2.04M
SG&A % of Revenue-------------10193.55%11406.45%12135.48%11612.9%12635.48%9016.13%6580.65%
Research & Development9.84M11.03M8.46M6.99M4.02M4.82M5.42M4.98M4.1M7.26M5.84M5.93M5.47M4.97M5.38M5.02M5.42M3.85M5.26M3.29M
R&D % of Revenue-------------16038.71%17341.94%16200%17474.19%12432.26%16983.87%10619.35%
Other Operating Expenses0000000000000-48K000-149K-131K-605K
Operating Income-16.28M-15.75M-13.21M-11.18M-8.13M-8.14M-8.76M-8.57M-7.9M-10.32M-8.86M-9.58M-9.63M-8.1M-8.88M-8.75M-8.99M-7.74M-8.03M-5.3M
Operating Margin %--------------26132.26%-28648.39%-28235.48%-28987.1%-24967.74%-25900%-17100%
Operating Income Growth %-100.3%-93.49%-50.82%-30.4%-2.89%21.1%1.17%10.52%17.97%-27.37%0.23%-9.44%-7.2%-4.66%-10.61%-65.12%-92.96%-26.37%--
EBITDA-16.14M-15.59M-13.01M-10.94M-7.88M-7.9M-8.51M-8.32M-7.65M-10.07M-8.62M-9.34M-9.4M-7.88M-8.68M-8.57M-8.82M-7.56M-8.01M-5.29M
EBITDA Margin %--------------25419.35%-27987.1%-27632.26%-28454.84%-24393.55%-25832.26%-17077.42%
EBITDA Growth %-104.63%-97.43%-52.87%-31.4%-3.06%21.58%1.21%10.93%18.63%-27.78%0.69%-9.07%-6.6%-4.21%-8.34%-61.81%-90.48%-23.58%--
D&A (Non-Cash Add-back)149K163K195K242K245K245K245K249K251K249K245K236K230K221K205K187K165K178K21K7K
EBIT-7.3M-28.08M-11.11M-4.56M7.68M-13.68M-10.16M-21.67M-7.58M-10.42M-7.77M-8.97M-8.19M-8.05M-8.17M-3.71M-8.99M1.61M-7.9M-4.7M
Net Interest Income-242K-314K792K690K628K-100K-251K-327K-326K-258K-167K-191K102K0-176K-365K-175K-11K-14K-15K
Interest Income1.32M1.1M953K926K934K290K236K240K320K415K502K453K711K-343K70K0000
Interest Expense1.56M1.42M161K236K306K390K487K567K646K673K669K644K609K-519K435K175K11K14K15K
Other Income/Expense7.42M-13.74M1.94M6.38M15.51M-5.93M-1.89M-13.67M-319K-777K426K-35K838K3.02M193K4.6M8.11M9.34M-8.13M-11.78M
Pretax Income-8.86M-29.5M-11.27M-4.8M7.38M-14.07M-10.65M-22.24M-8.22M-11.1M-8.44M-9.61M-8.79M-5.08M-8.69M-4.15M-874K1.6M-16.16M-17.08M
Pretax Margin %--------------16396.77%-28025.81%-13383.87%-2819.35%5148.39%-52135.48%-55096.77%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-8.86M-29.5M-11.27M-4.8M7.38M-14.07M-10.65M-22.24M-8.22M-11.1M-8.44M-9.61M-8.79M-5.08M-8.69M-4.15M-874K1.6M-16.16M-17.08M
Net Margin %--------------16396.77%-28025.81%-13383.87%-2819.35%5148.39%-52135.48%-55096.77%
Net Income Growth %-220.08%-109.59%-5.85%78.43%189.76%-26.84%-26.21%-131.3%6.53%-118.28%2.91%-131.72%-906.29%-418.48%46.24%75.71%80.48%115.23%--
Net Income (Continuing)-8.86M-29.5M-11.27M-4.8M7.38M-14.07M-10.65M-22.24M-8.22M-11.1M-8.44M-9.61M-8.79M-5.08M-8.69M-4.15M-874K1.6M-16.16M-17.08M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.14-0.54-0.21-0.090.23-0.40-0.33-0.74-0.28-0.38-0.29-0.33-0.300.37-0.290.020.250.07-0.69-0.69
EPS Growth %-160.87%-35%36.36%87.42%182.14%-5.26%-13.79%-124.24%6.67%-202.7%0%-2188.61%-220%444.92%57.97%102.29%204.17%112.13%--
EPS (Basic)-0.14-0.54-0.21-0.090.23-0.40-0.33-0.74-0.28-0.38-0.29-0.33-0.300.37-0.290.020.250.07-0.69-0.69
Diluted Shares Outstanding62.36M54.9M54.89M51.49M31.68M35.56M32.01M29.88M29.2M28.98M28.92M28.92M28.92M28.9M28.89M28.81M28.69M23.33M23.33M24.8M
Basic Shares Outstanding62.36M54.9M54.89M51.49M31.68M35.56M32.01M29.88M29.2M28.98M28.92M28.92M28.92M28.9M28.89M28.81M28.69M23.33M23.33M24.8M
Dividend Payout Ratio--------------------